---
title: "Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293072568.md"
description: "Abbott Laboratories (ABT) shares rose 1.87% to $100.68, outperforming peers like Johnson & Johnson, Pfizer, and Merck during a broader market decline. This marks the third consecutive day of gains for ABT, with trading volume significantly exceeding its 50-day average."
datetime: "2026-07-17T20:35:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293072568.md)
  - [en](https://longbridge.com/en/news/293072568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293072568.md)
generator: "portal-rs"
---

# Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories (ABT) rallied 1.87% to $100.68 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.

This was the stock's third consecutive day of gains.

Abbott Laboratories closed 26.77% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.23% to $253.04, Pfizer Inc. (PFE) fell 0.36% to $25.05, and Merck & Co. Inc. (MRK) fell 0.10% to $127.50.

Trading volume (19.8 M) eclipsed its 50-day average volume of 13.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-17-26 1635ET

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [IFP Advisors Inc Grows Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/298421693.md)
- [Amundi Grows Position in Abbott Laboratories $ABT](https://longbridge.com/en/news/298275328.md)
- [Proficio Capital Partners LLC Makes New $1.10 Million Investment in Abbott Laboratories $ABT](https://longbridge.com/en/news/298128402.md)
- [Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?](https://longbridge.com/en/news/297586976.md)
- [Continuous glucose monitors are about to get more complicated](https://longbridge.com/en/news/297807418.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**